Association of clinical and epidemiological characteristics with COVID-19 BNT162b2 mRNA vaccine short-term adverse reactions in healthcare workers.
Filippos FilippatosElizabeth Barbara TatsiCharilaos DellisNick DessyprisVassiliki SyriopoulouAthanasios MichosPublished in: Human vaccines & immunotherapeutics (2021)
The administration of the BNT162b2 vaccine in our HCWs cohort had a good safety profile with the most common ARs being self-limited. An increasing rate of SARs following the second vaccine dose was noticed. Rare but severe possible ARs should be further investigated.